Establishing RIs for TSH in Children Under the Age of Two Years
Establishing Reference Intervals for Thyroid Stimulating Hormone in Children Under the Age of Two Years
1 other identifier
observational
131
1 country
1
Brief Summary
Reference intervals (RIs) of thyroid-stimulating hormone (TSH) and free thyroxine (FT4) are age, assay and population specific. Currently, the age and assay-specific RIs for TSH are not available for children under two years of age. This study aimed to establish reference intervals for serum concentrations of TSH and FT4 in healthy children aged 1-24 months as per CLSI C28-A3 guidelines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2019
CompletedFirst Submitted
Initial submission to the registry
May 5, 2021
CompletedFirst Posted
Study publicly available on registry
May 7, 2021
CompletedMay 7, 2021
May 1, 2021
8 months
May 5, 2021
May 5, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Establishing Reference Intervals for Thyroid Stimulating Hormone in Children under the age of two years
This study aimed to establish reference intervals for serum concentrations of TSH and FT4 in healthy children aged 1-24 months as per CLSI C28-A3 guidelines.
August 2018 to March 2019
Eligibility Criteria
Healthy children from 1 to 24 months
You may qualify if:
- Healthy children from 1 to 24 months
You may not qualify if:
- recent illness, hospitalization, medication and maternal history of thyroid-related diseases, recent abnormal total leucocyte or neutrophil count in the medical record or positive microbial cultures, history of any diagnosed disease or infection, history of hospitalization during the previous four weeks, congenital hypothyroidism or transient congenital hypothyroidism, history of maternal thyroid illness, or any medications with potential influences on the thyroid function, such as amiodarone, anti-epileptic drugs, glucocorticoids
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Aga Khan University
Karachi, Sindh, 3500, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Siraj Muneer
Aga Khan University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident
Study Record Dates
First Submitted
May 5, 2021
First Posted
May 7, 2021
Study Start
August 1, 2018
Primary Completion
March 30, 2019
Study Completion
March 30, 2019
Last Updated
May 7, 2021
Record last verified: 2021-05